Endodontics Market worth 1.61 Billion USD by 2022

The report "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022", The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes.

Browse 194 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/endodontics-market-222473576.html
Early buyers will receive 10% customization on reports.

The consumables segment to dominate the endodontics market during the forecast period

Based on product, the endodontics market is segmented into consumables and instruments. The consumables segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the growing number of root canal procedures globally.

Dental clinics to witness the highest growth rate during the forecast period

On the basis of end users, the endodontics market is segmented into dental clinics, dental hospitals, and dental academic & research institutes. The dental clinics segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.

Europe dominated the market in 2016

Europe accounted for the largest share of the endodontics market in 2016, followed by North America. The large share of this region is attributed to the increasing prevalence of dental diseases, growth in the aging population, increasing demand for advanced dental procedures, growing dental tourism in some European countries, increasing number of dental clinics and hospitals, and increasing dental care expenditure in countries such as Germany and the UK.

The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).

Vaccine Adjuvants Market worth 769.4 Million USD by 2021

The report "Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.

Browse 90 market data tables with 42 figures spread through 156 pages and in-depth TOC on "Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html
Early buyers will receive 10% customization on reports.

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases.

The report segments this market into product type, route of administration, disease type, applications, and application categories. On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. Particulate adjuvants are expected to account for the largest share of the market. Adjuvant emulsions, on the other hand, are projected to grow at the highest CAGR from 2016 to 2021 due to factors such as the proven efficacy and relatively fewer safety issues involved in the use of adjuvant emulsions.

On the basis of route of administration, the vaccine adjuvants market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. The rapidly growing geriatric population and increasing need for development of better vaccines for improved immunization are the key factors propelling the growth of this market.

On the basis of disease type, the vaccine adjuvants market includes infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High incidences of diseases and research investments in life sciences are the major factors driving the growth of this market.

Based on applications, the global vaccine adjuvants market is segmented into research and commercial applications. Research applications are expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by factors such as increasing need for better immunization for the increasing geriatric population and increasing government funding in research to meet the unmet needs for safe and effective vaccine adjuvants.

https://www.marketsandmarkets.com/pdfdownload.asp?id=152603894

On the basis of application categories, the vaccine adjuvants market is segmented into human and veterinary adjuvants. Adjuvants for humans are expected to account for the largest share of the global vaccine adjuvants market in 2016 and are expected to grow at a higher CAGR in the application category segment.

The key players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Creatinine Assay Kits Market worth 245.4 Million USD by 2022

The report "Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test, Creatinine-PAP, and ELISA), Sample (Blood, Serum, Urine, Saliva, CSF, Tissue Homogenate, Sweat) and Region (North America, Europe, Asia and RoW) - Global Forecast to 2022", 

The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%. Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are the key drivers of the global creatinine assay kits market.

Browse 84 market data Tables and 22 Figures spread through 192 Pages and in-depth TOC on "Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test, Creatinine-PAP, and ELISA), Sample (Blood, Serum, Urine, Saliva, CSF, Tissue Homogenate, Sweat) and Region (North America, Europe, Asia and RoW) - Global Forecast to 2022"https://www.marketsandmarkets.com/Market-Reports/creatinine-assay-kits-market-73499229.html
Early buyers will receive 10% customization on reports.

The Jaffe’s kinetic test kits segment dominated the market in 2017

The creatinine assay kits market, by type, is segmented into Jaffe’s kinetic test kits, creatinine-PAP test kits, and ELISA test kits. In 2017, Jaffe’s kinetic test kits accounted for the largest share of the market. Jaffe’s kinetic test is the oldest and most conventional method for creatinine measurement. Additionally, the wide product availability, as well as the cost-effectiveness of these kits, are some of the major factors responsible for the large share of this segment.

Based on type of sample, the blood/serum segment is expected to register the highest CAGR during the forecast period

Based on type of sample, the creatinine assay kits market is segmented into blood/serum, urine, and other samples. Other samples mainly include saliva, cerebrospinal fluid, tissue homogenate, and sweat. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most newly developed creatinine measurement kits are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration. These are the major factors responsible for the increasing adoption of this sample type.

In 2017, North America dominated the creatinine assay kits market

In 2017, North America dominated the market followed by Europe. The large share of North America is attributed to factors such as increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction), and the implementation of favorable government initiatives to increase awareness of and encourage research pertaining to kidney diseases.

The creatinine assay kits market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Crystal Chem (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US).

creatinine assay kits market Download 

Protein Engineering Market worth $1,463.0 Million by 2020

The report “Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020”, provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Browse 100 market data tables and 53 figures spread through 180 pages and in-depth TOC on “Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html
Early buyers will receive 10% customization on reports.

The global protein engineering market is poised to reach $1,463.0 million by 2020 from $610.3 million in 2014, at a CAGR of 15.7% from 2015 to 2020.

Factors such as increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery are the major drivers of the protein engineering market. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are hindering the market.

The protein engineering market is segmented on the basis of product, technology, protein type, end user, and region. By product, the protein engineering market is categorized into instruments, reagents, and services and software. The instruments segment accounted for the largest share 41.4% of the global protein engineering market in 2014.

The protein engineering technology market is categorized into rational protein design, and irrational protein design. In this market, rational protein design is the largest and fastest growing segment. On the basis of end user the protein engineering market is classified into academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. In this market, pharmaceutical and biotechnology companies segment holds the major share followed by contract research organizations.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.

On the basis of geography, the protein engineering market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is further segmented into U.S. and Canada. Asia is further segmented into China, Japan, India and Rest of Asia. In 2014, North America accounted for the largest share of the protein engineering market, followed by Europe. Both markets are estimated to register double-digit growth rates over the next five years.

Key players operating in the protein engineering market are Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Protein Engineering Market Download PDF

Bioinformatics Market worth 16.18 Billion USD by 2021

The report "Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021", The bioinformatics market is projected to reach USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing at a CAGR of 21.1% during the forecast period.

Browse 136 market data tables and 47 figures spread through 184 pages and in-depth TOC on “Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021”
https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html
Early buyers will receive 10% customization on reports.

Growing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, growing application of bioinformatics, and improved collaborative ties between companies and research institutes are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common data formats for integration of data, shortage of skilled bioinformatics professionals, and lack of adequate user-friendly tools are the major factors restraining the growth of this market.

The bioinformatics market is segmented on the basis of sector, products and services, application, and region. Based on sector, the bioinformatics market is categorized into medical biotechnology, academics, animal biotechnology, agricultural technology, environmental biotechnology, forensic biotechnology, and other sectors (homeland security and defense, law enforcement groups, bioweapon creation, and evolutionary biotechnology). In 2016, the medical biotechnology segment is expected to account for the largest share of the bioinformatics market. This is attributed to the increasing use of bioinformatics in drug discovery and development processes for the faster development of safe and effective drugs at reduced costs.

On the basis of products and services, the bioinformatics market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. The knowledge management tools segment is expected to account for the largest market share in 2016. However, the bioinformatics platforms segment is expected to grow at the highest CAGR during the forecast period; high growth in this segment can be attributed to the advantages of bioinformatics platforms, such as reduction in overall time for processing data, phylogenetic analysis, and identification of sequence similarity.

Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, molecular phylogenetics, and other applications (glycomics, cytomics, physiomics, and interactomics). The genomics segment is expected to account for the largest market share in 2016.. The increasing use of pharmacogenomics is a major factor contributing to the growth of this segment.

North America is expected to account for the largest share of the bioinformatics market in 2016. The increasing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and presence of a large number of market players and research institutes are driving the growth of the bioinformatics market in this region.

Major players operating in the bioinformatics market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and Agilent Technologies (U.S.).

Bioinformatics Market

Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022

The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population.

https://www.marketsandmarkets.com/PressReleases/endoscopic-vessel-harvesting.asp

The market is segmented on the basis of product, usability, vessel type, application, and region. On the basis of product, the global market is segmented into EVH systems, endoscopes, and accessories. The EVH systems segment accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. This can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposable nature of these products.

Based on usability, the market is segmented into disposable and reusable. In 2017, the disposable segment commanded the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period primarily due to the rising preference for disposable devices over reusable owing to the advantages offered.

Based on vessel type, the market is segmented into saphenous vein and radial artery. The saphenous vein segment is expected to register highest CAGR during the forecast period. This can be attributed to the advantages offered by saphenous vein in terms of wound complications, reduced pain, and aesthetics.

Based on application, the market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment is expected to register the highest CAGR during the forecast period primarily due to the rising prevalence of cardiovascular diseases and increasing geriatric population.

The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high burden of cardiovascular diseases (CVDs), the launch of the Hospital Readmissions Reduction Program (HRRP) and Episode-based Payment Models (EPMs), increasing incidence of cardiac diseases, and growing preference for minimally invasive harvesting procedures.

The availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH is expected to restrain the growth of this market during the forecast period.

The major players in this market include Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Gastrointestinal / GI Stent Market worth 452.6 Million USD by 2022

The report "Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022", The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stent market. The base year considered for the study is 2016, while, the forecast period is 2017 to 2022.

Browse 177 market data Tables and 32 Figures spread through 182 Pages and in-depth TOC on "Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/gastrointestinal-gi-stent-market-167758126.html
Early buyers will receive 10% customization on reports.

“By product, the biliary stent segment accounted for the largest share of the gastrointestinal stent market in 2016.”

On the basis of product, the biliary stent segment accounted for the largest share of the global gastrointestinal stent market. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as growth in the number of surgical procedures for the treatment of these diseases.

“By disease type, the biliary diseases segment held the largest market share of the gastrointestinal stent market in 2016.”

On the basis of disease type, the biliary diseases segment accounted for the largest share of the gastrointestinal stent market. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.

“The ambulatory surgery centers segment is expected to witness the highest growth rate in the gastrointestinal stent market, by end user, during the forecast period.”

Based on end user, the ambulatory surgery centers segment is expected to register the highest CAGR during the forecast period. Scheduling delays for operation, slow operating room turnover times, and the need for increasing the number of operating rooms in hospitals are the major factors supporting the growth of ASCs.

“North America dominated the gastrointestinal stent market in 2016.”

North America accounted for the largest share of the gastrointestinal stent market in 2016, followed by Europe and Asia Pacific. The developed healthcare system, rising geriatric population, and high prevalence of gastrointestinal cancers are the major factors responsible for the large share of North America in the gastrointestinal stent market.

The prominent players in the global gastrointestinal stent market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=167758126

Sunitinib Malate Market worth 76.7 Million USD by 2021

The report "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)", The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.

Browse 14 market data Tables spread through 26 Pages and in-depth TOC on "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)"
https://www.marketsandmarkets.com/Market-Reports/sunitinib-malate-market-194614514.html
Early buyers will receive 10% customization on reports.

A number of factors, such as increasing incidence of pancreatic cancer, availability of a limited number of drug therapeutic options for the treatment of advanced pancreatic neuroendocrine tumors, and poor diagnosis rate in the early stages of pancreatic cancer are driving the demand of sunitinib malate in the treatment of pancreatic cancer. Also, the overall number of patients who are eligible for taking sunitinib malate is expected to grow at a high CAGR during the forecast period.

In this report, the market is segmented into seven country-level segments, namely, the U.S., Germany, France, the U.K., Italy, Spain, and Japan. The U.S. is expected to dominate this market primarily due to the higher number of patients suffering from pancreatic cancer in the country. However, the market in the U.K. is expected to witness the highest growth rate during the forecast period.

This report contains detailed analysis of the sunitinib malate market for pancreatic cancer in terms of epidemiology, number of drug-treated patients suffering from pancreatic neuroendocrine tumors (pNET), percentage of patients eligible for taking sunitinib malate, penetration of sunitinib malate in pNET patients, number of pancreatic cancer patients, incidence rate of pancreatic cancer, 5-year survival rate of pNET patients, penetration of drug therapy in pancreatic cancer treatment, and trends in the adoption of sunitinib malate. This report also includes pricing analysis of sunitinib malate in all G7 countries and year-on-year market size of sunitinib malate for pancreatic cancer from 2010 to 2021.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=194614514

Endoscopic Vessel Harvesting Market worth 504.8 Million USD by 2022

The report "Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022", The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period.

Browse 69 tables and 31 figures spread through 113 pages and in-depth TOC on "Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/endoscopic-vessel-harvesting-market-52677973.html
Early buyers will receive 10% customization on reports.

The key factors driving the growth of this market include the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. However, the availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH may hinder the growth of this market to a certain extent.

By product, the EVH systems segment accounted for the largest share of the market in 2017

On the basis of product, the endoscopic vessel harvesting market is segmented into EVH systems, endoscopes, and accessories. In 2017, the EVH systems segment accounted for the largest share of the global market. The large share of this segment can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposable nature of these products.

By usability, the disposable segment held the largest market share in 2017

Based on usability, the market is segmented into disposable and reusable products. The disposable segment commanded the largest share of the endoscopic vessel harvesting market in 2017. The large share of this segment can be attributed to the rising preference for disposable devices over reusable owing to the advantages offered.

By vessel type, the saphenous vein segment held the largest market share in 2017

Based on vessel type, the market is segmented into saphenous vein and radial artery. The saphenous vein segment commanded the largest share of the endoscopic vessel harvesting market in 2017. The large share of this segment can be attributed to the significant advantages offered by the saphenous vein in terms of wound complications, reduced pain, and aesthetics.

By application, the coronary artery disease segment held the largest market share in 2017

Based on application, the market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment commanded the largest share of the endoscopic vessel harvesting market in 2017. The large share of this segment can be attributed to the rising prevalence of cardiovascular diseases and increasing geriatric population.

North America dominated the market in 2017

In 2017, North America accounted for the largest share of the endoscopic vessel harvesting market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as high burden of cardiac diseases in the US and Canada, the launch of the Hospital Readmissions Reduction Program (HRRP) and Episode-based Payment Models (EPMs) in the US, and growing preference for minimally invasive harvesting procedures in Canada are contributing to the large share of North America.

The endoscopic vessel harvesting market in Europe is expected to witness high growth during the forecast period. This can be attributed to the rising number of CABG procedures and growth in the geriatric population in the region.

The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=52677973

Pain Management Devices Market worth 4.64 Billion USD by 2021

The report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

Pain Management Devices Market

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

Anesthesia Monitoring Devices Market worth 1,616 Million USD by 2020

The report "Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020", defines and segments the market with analysis and forecast of revenue. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is projected to reach USD 1,616 Million by 2020, at a CAGR of 12.0% from 2015 to 2020.

Browse 75 market data Tables and 83 Figures spread through 129 Pages and in-depth TOC on "Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/anesthesia-monitoring-devices-market-57663369.html
Early buyers will receive 10% customization on reports.

Anesthesia monitoring devices are available as a part of sophisticated multi-parameter patient monitors, or as a component of a high-end anesthesia workstation, or as a standalone unit. Technological changes as well as the growing usage of anesthesia monitors in the freestanding surgery centers are contributing to the increased growth of the anesthesia monitor devices market. The global market is expected to grow due to the rise in aging population, increasing number of surgeries, growing awareness among physicians, and advancements in technology. Despite this, high cost of anesthesia monitoring devices and the availability of conventional techniques are the major restraining factors of this market.

This market is segmented and forecasted on the basis of product, end user, and geography. The product comprises of advanced anesthesia monitors, basic anesthesia monitors, integrated anesthesia workstation, and others (IT enabled). The advanced anesthesia monitors are further subsegmented into anesthesia gas monitors, depth of anesthesia, standalone capnography monitors, and others (MRI compatible anesthesia monitors). On the basis of end user, the market is segmented into hospitals and ambulatory surgery centers. The market is further segmented and forecasted on the basis of major regions, which include North America, Europe, Asia-pacific and the rest of the world (RoW).

In 2014, 31.5% of the global anesthesia monitoring devices market was dominated by North America. The market in North America is growing due to increased patient safety and awareness among doctors and patients for low flow aesthetic agents. The European market, growing due to technological advancements, has been dominated majorly by Drägerwerk AG & Co. KGaA. However, the North American and European markets are moving toward the maturity phase.

https://www.marketsandmarkets.com/Market-Reports/anesthesia-monitoring-devices-market-57663369.html

This report also includes the market share, approaches for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis, and price analysis by product. In this report, market metrics are also included, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profile of key players in the market, including major companies which provide anesthesia monitoring devices as a product.

Dental Bone Graft Substitutes Market worth 664.3 Million USD by 2021

The report "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021", The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts.

Browse 66 market data tables with 69 figures spread through 140 pages and in-depth TOC on "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" 
https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html
Early buyers will receive 10% customization on reports.

This report mainly considers four types of dental bone graft substitutes – xenograft, synthetic bone grafts, allograft, and demineralized allograft. Using patient’s own bone (autograft) has traditionally been the most preferred method of bone grafting; however, increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease. Because of these benefits, synthetic bone graft is the fastest-growing type in the dental bone graft substitutes market.

In this report, the dental bone graft substitutes market is segmented into four major geographic segments, namely, North America, Europe, Asia-Pacific, and Rest of the World. Europe is estimated to account for the largest share of the overall dental bone graft substitutes market in 2016. Europe is the region of origin of implant dentistry; therefore, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the European dental market are the increase in aging population, governmental expenditure on oral healthcare across Europe, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.

This research study is aimed at identifying emerging trends and opportunities in the global dental bone graft substitutes market. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global dental bone graft substitutes market on the basis of type, application, product, and region.

Apart from the market segmentation, this report also makes use of the Porter’s five forces analysis, which provides an in-depth analysis of the market by providing market dynamics, such as drivers, restraints, and opportunities in the global dental bone graft substitutes market.

Dental Bone Graft Substitutes Market

Prominent players in this market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea).

Foot and Ankle Devices Market worth 5.41 Billion USD by 2020

The report “Foot and Ankle Devices Market by Product (Orthopedic Implants (External Fixation, Internal Fixation), Prostheses, Bracing), by Cause of Injury (Diabetes, Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, Trauma, Bunions) - Trends & Global Forecasts to 2020”, analyzes and studies the major market drivers, restraint, challenges, and opportunities.

Browse 127 tables and 40 figures spread through 194 Pages and in-depth TOC on "Foot and Ankle Devices Market by Product (Orthopedic Implants (External Fixation, Internal Fixation), Prostheses, Bracing), by Cause of Injury (Diabetes, Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, Trauma, Bunions) - Trends & Global Forecasts to 2020"
https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html
Early buyers will receive 10% customization on reports.

This report studies the global foot and ankle devices market for the forecast period of 2015 to 2020. This market is expected to reach USD 5.41 Billion by 2020 from USD 3.82 Billion in 2015 at a CAGR of 7.2% during the forecast period.

The global foot and ankle devices market is segmented on the basis of products, applications, and regions.

Based on products, the foot and ankle devices market is categorized into orthopedic implants and devices, prostheses, and bracing and support devices. In 2015, the orthopedic implants and devices segment is estimated to account for the major share of the foot and ankle devices market.

Based on the cause of injury, the market is segmented into trauma, diabetes, neurological disorders, and others (osteoporosis, rheumatoid arthritis, osteoarthritis, hammertoe, and bunions). In 2015, the others segment is estimated to account for the major share of the foot and ankle devices market.

On the basis of regions, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which comprises Latin America, Africa, and the Middle East. In 2015, North America accounted for the largest share of the foot and ankle devices market, followed by Europe, Asia-Pacific, and the RoW. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serves as a revenue pocket for companies offering foot and ankle devices.

Growth in the number of sports injuries, expected global rise in the prevalence of diabetes, rising prevalence of arthritis in Australia and the U.S., regular entry of new products in the market, and rising geriatric population resulting in the growing incidence of bone injuries are the major factors driving this market. On the other hand, the high cost of some foot and ankle devices and excise tax on medical devices in the U.S. and are expected to restrain the growth of the market. In addition to this, a lack of trained professionals is a major challenge for the global foot and ankle devices market. However, the introduction of biologics to treat foot and ankle disorders, coupled with expansion & penetration in Brazil, Russia, India, China, and South Africa, are posing lucrative opportunities for the foot and ankle devices market.

Foot and Ankle Devices Market

Some major players in the global foot and ankle devices market include Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.)